Increased Survival in Patients With Molybdenum Cofactor Deficiency Type A Treated With Cyclic Pyranopterin Monophosphate

Documenti analoghi

• Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies
  di: Bernd C. Schwahn, et al.
  Pubblicazione: (2024)
• Valine Restriction Extends Survival in a Drosophila Model of Short‐Chain Enoyl‐CoA Hydratase 1 (ECHS1) Deficiency
  di: Sarah Mele, et al.
  Pubblicazione: (2024)
• From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D‐Bifunctional Protein Deficiency in a Multicentre International Case Series
  di: U. Diaz‐Moreno, et al.
  Pubblicazione: (2025)
• Alternating cerebral edema and arterial dilations in Molybdenum cofactor deficiency type‐A
  di: Amane Matsuura, et al.
  Pubblicazione: (2024)
• Long‐Term Follow‐Up of Patients With Transaldolase Deficiency
  di: Marco Scaglione, et al.
  Pubblicazione: (2026)